polymyxin B sulfate


Also found in: Dictionary.
Related to polymyxin B sulfate: Bacitracin zinc

polymyxin B sulfate

an antibiotic.
indication It is commonly prescribed for infections of the eye and urinary tract.
contraindication Known hypersensitivity to this drug prohibits its use.
adverse effects When it is given topically, allergies are the most common problem.

polymyxin B sulfate (sul´fāt),

n brand names: Aerosporin;
drug class: ophthalmic antiinfective;
action: inhibits cell wall permeability in susceptible organism;
use: superficial external ocular infections.
References in periodicals archive ?
Different antibiotic cream formulations using polymyxin B sulfate and lupulone were prepared.
5 mg neomycin base and polymyxin B sulfate, equivalent to 10,000 polymyxin B units.
Synergistic responses were observed when ND-497 was used in combination with neomycin sulfate, streptomycin sulfate or polymyxin B sulfate (Table 2).
Polymyxin B Sulfate for Injection is indicated for the treatment of acute infections caused by susceptible strains of pseudomonous aeruginosa.
Contract awarded for Polymyxin b sulfate 500,000 iu road, im, iv.
Contract awarded for Drugs (acettato methylprednisolone or triamcinolone, polymyxin b sulfate, multivitaminas powder).
Polymyxin B Sulfate 10,000 IU + Bacitracin Zinc 500 IU per gram of ointment.
Neo-Polycin[TM]; Neo-Polycin[TM] HC; Polycin[TM]; Neomycin and Polymyxin B Sulfates with Dexamethasone Ophthalmic Ointments are the latest additions to the Fera product offering making it the largest Rx ophthalmic ointment portfolio available in the US.
The products include Bacitracin; Bacitracin Zinc and Polymixin B Sulfate; Gentamicin Sulfate, Neomycin and Polymyxin B Sulfates and Bacitracin Zinc; Neomycin and Polymyxin B Sulfates and Dexamethasone; Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone Acetate as well Erythromycin Ophthalmic Ointments USP.
In a phase III clinical trial compared to Neomycin, Polymyxin B sulfates and Hydrocortisone otic solution (NPH), CETRAXAL[R] obtained a clinical cure rate of 93.
Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment USP ("Neomycin and Polymyxin B").
AMEX:AKN) today announced that it has signed a commercial manufacturing supply agreement with X-Gen Pharmaceuticals for the product, Neomycin and Polymyxin B Sulfates Solution for Irrigation USP.